SCHEMBL5024503

SCHEMBL5024503

O=C(O)c1ccc(F)cc1-c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R2 Q9NPC1 4/20 0.51
MAPT P10636 1/20 0.49
DHODH Q02127 1/20 0.49
PTPN1 P18031 2/20 0.49
KEAP1 Q14145 1/20 0.48
DCLRE1B Q9H816 1/20 0.47
LTB4R Q15722 3/20 0.47
AKR1C2 P52895 2/20 0.47
AKR1C1 Q04828 2/20 0.47
HNF4A P41235 2/20 0.47
ACMSD Q8TDX5 2/20 0.47
BCL2L1 Q07817 1/20 0.47
BAD Q92934 1/20 0.47
HTT P42858 1/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
USP2 O75604 1/20 0.46
ALDH1A1 P00352 1/20 0.46
DHFR P00374 1/20 0.46
CA1 P00915 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10794588 0.96 DHODH (0.54) LTB4R2MAPTDHODHPTPN1KEAP1
SCHEMBL17797021 0.90 HSD17B10 (0.51) LTB4R2DHODHKEAP1DCLRE1BLTB4R
SCHEMBL31676805 0.90 HSD17B10 (0.51) LTB4R2DHODHKEAP1DCLRE1BLTB4R
SCHEMBL17797037 0.89 DCLRE1B (0.56) LTB4R2DHODHKEAP1DCLRE1BLTB4R
SCHEMBL9857579 0.87 BCL2L1 (0.57) LTB4R2DHODHPTPN1DCLRE1BLTB4R
SCHEMBL29519530 0.85 HTT (0.48) LTB4R2MAPTDHODHAKR1C2AKR1C1
SCHEMBL11250307 0.85 HTT (0.48) LTB4R2MAPTDHODHAKR1C2AKR1C1
SCHEMBL1927478 0.85 BCAT2 (0.61) MAPTHTT
SCHEMBL31585949 0.85 FOLH1 (0.57) LTB4R2MAPTDHODHPTPN1KEAP1
SCHEMBL17796951 0.85 FOLH1 (0.57) LTB4R2MAPTDHODHPTPN1KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3029026-B1 NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME DONG A ST CO LTD (KR) 2018-12-05 EP disclosed
EP-3029026-A1 NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME Dong-A ST Co., Ltd. (KR) 2016-06-08 EP disclosed
CN-101318932-A 2'-oxatyl-5' fluorine biphenyl derivant, preparation and application thereof UNIV DONGHUA (CN) 2008-12-10 CN disclosed
EP-1311475-B1 AMINOCYCLOHEXANE DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-08-06 EP disclosed
EP-0986384-A4 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIV PITTSBURGH (US) 2004-09-15 EP disclosed
US-6693123-B2 (4-(3-PYRIDYLAMINOMETHYLENE)-2-PHENYLBENZOYL)-N -METHYLMETHIONINE, METHYL ESTER FOR EXAMPLE; RESTENOSIS, HYPERPLASIA UNIVERSITY OF PITTSBURGH 2004-02-17 US disclosed
EP-0873123-B1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIV PITTSBURGH (US) 2003-04-09 EP disclosed
US-20020193596-A1 Inhibitors of protein isoprenyl transferases UNIVERSITY OF PITTSBURGH (US) 2002-12-19 US disclosed
US-6310095-B1 INHIBITING OR TREATING CANCER, TREATING INTIMAL HYPERPLASIA ASSOCIATED WITH RESTENOSIS AND ATHEROSCLEROSIS, INHIBITING POST-TRANSLATIONAL MODIFICATION OF ONCOGENIC RAS PROTEIN BY PROTEIN FARNESYLTRANSFERASE AND/OR GERANYLGERANYLTRANSFERASE UNIVERSITY OF PITTSBURGH 2001-10-30 US disclosed
US-6221865-B1 INHIBITORS OF PROTEIN FARNESYLTRANSFERASE AND PROTEIN GERANYLGERANYLTRANSFERASE. UNIVERSITY OF PITTSBURGH 2001-04-24 US disclosed
US-6204293-B1 INHIBITING POST-TRANSLATIONAL MODIFICATION OF THE ONCOGENIC RAS PROTEIN BY PROTEIN FARNESYLTRANSFERASE, PROTEIN GERANYLGERANYLTRANSFERASE, OR BOTH UNIVERSITY OF PITTSBURGH 2001-03-20 US disclosed
EP-0986384-A1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 2000-03-22 EP disclosed
WO-1998050031-A1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1998-11-12 WO disclosed
WO-1998050030-A1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1998-11-12 WO disclosed
WO-1998050029-A1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1998-11-12 WO disclosed
EP-0057503-B1 PRODUCTION OF HYDROXY ARYLOPHENONES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-03-20 EP disclosed
US-4453010-A Production of hydroxy arylophenones IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1984-06-05 US disclosed
EP-0057503-A1 Production of hydroxy arylophenones IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193596-A1 Inhibitors of protein isoprenyl transferases LANCL1, FNTB, DHCR7 LTB4R2 2026/4885MAPT 4674/4885DHODH 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.